US FDA scientists point to gaps in approval, marketing

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1034卷 / 1期

关键词：

Marketing; Prescription Drug; Health Impact; Early Warning; Adverse Health;

D O I：

10.2165/00128415-200510340-00006

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[31] US FDA defends approval of Alzheimer's disease drug
Jaffe, Susan
[J]. LANCET, 2021, 398 (10294): : 12 - 12
[32] Fluarix® Quadrivalent vaccine garners approval from the US FDA
Breeze, Sophie
[J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (01) : 11 - 11
[33] Clamp down on Rx drugs without US FDA approval
[J]. Reactions Weekly, 2006, 1106 (1) : 3 - 3
[34] FDA's time pressures hinder US pharma approval
不详
[J]. TCE, 2008, (803): : 12 - 12
[35] US FDA's safety monitoring of drugs with expedited approval
Furlow, Bryant
[J]. LANCET ONCOLOGY, 2016, 17 (03): : 281 - 281
[36] MedImmune receives US FDA approval for refrigerated influenza vaccine
不详
[J]. EXPERT REVIEW OF VACCINES, 2007, 6 (01) : 5 - 5
[37] US FDA advisors recommend the approval of obesity drug Qnexa®
Dowdall, Michael
[J]. CLINICAL LIPIDOLOGY, 2012, 7 (02) : 133 - 134
[38] Fluarix® Quadrivalent vaccine garners approval from the US FDA
Breeze, Sophie
[J]. FUTURE VIROLOGY, 2013, 8 (02) : 110 - 111
[39] Pfizer and Novartis seek US FDA approval for their MenB vaccines
不详
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (10) : 2779 - 2779
[40] US FDA advisory panel votes against approval for lorcaserin
[J]. Reactions Weekly, 2010, 1320 (1) : 3 - 3

← 1 2 3 4 5 →